Charles E. Riordan
Impact in
- Psychiatry and Mental health top 10%
- Attention Deficit Hyperactivity Disorder
- Schizophrenia research and treatment
-
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 3
-
- Opioid Use Disorder Treatment 3
- Co-authors
- Herbert D. Kleber (6 shared papers)Frank H. Gawin (2 shared papers)Edward J. Khantzian (1 shared paper)Thomas R. Kosten (2 shared papers)Mark Topazian (1 shared paper)Mark S. Gold (1 shared paper)H D Kleber (1 shared paper)Raymond F. Anton (1 shared paper)
- Journals
- The American Journal of Drug and Alcohol Abuse (2 papers)The Journal of Nervous and Mental Disease (2 papers)Journal of Substance Abuse Treatment (1 paper)JAMA (1 paper)Journal of Drug Issues (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Charles E. Riordan
10 papers receiving 367 citations
Peers
Comparison fields: 5 of 48
- Psychiatry and Mental health 135
- Cellular and Molecular Neuroscience 159
- Toxicology 26
- Pharmacology 65
- Epidemiology 123
Countries citing papers authored by Charles E. Riordan
This map shows the geographic impact of Charles E. Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Riordan more than expected).
Fields of papers citing papers by Charles E. Riordan
This network shows the impact of papers produced by Charles E. Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Riordan. The network helps show where Charles E. Riordan may publish in the future.
Co-authors
The 16 scholars most cited alongside Charles E. Riordan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 98 | |
| 2 | 1984 | 94 | |
| 3 | 1987 | 68 | |
| 4 | 1981 | 52 | |
| 5 | The use of clonidine in detoxification from opiates. | 1980 | 39 |
| 6 | 1976 | 37 | |
| 7 | 1977 | 13 | |
| 8 | 1982 | 4 | |
| 9 | 1985 | 3 | |
| 10 | Pilot results of a new model of addiction treatment: managing addiction as a chronic disease. | 2014 | 1 |
| 11 | Keys to successful CPOE implementation. Connecticut hospital maintains a constant focus on improved patient safety as its top reason for implementing CPOE. | 2004 | 0 |
About Charles E. Riordan
Charles E. Riordan is a scholar working on Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health, Epidemiology, Pharmacology and Clinical Psychology, having authored 11 papers that have together received 409 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (3 papers), Substance Abuse Treatment and Outcomes (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Digital Mental Health Interventions (2 papers), Attention Deficit Hyperactivity Disorder (2 papers), Treatment of Major Depression (2 papers), Neurological disorders and treatments (1 paper) and Child and Adolescent Psychosocial and Emotional Development (1 paper). The work is most often cited by research in Psychiatry and Mental health (135 citations), Cellular and Molecular Neuroscience (159 citations), Toxicology (26 citations), Pharmacology (65 citations) and Epidemiology (123 citations). Charles E. Riordan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Herbert D. Kleber, Frank H. Gawin, Edward J. Khantzian, Thomas R. Kosten, Mark Topazian, Mark S. Gold, H D Kleber, Raymond F. Anton, W. Douglas Thompson and Brigitte A. Prusoff. Their work appears in journals such as The American Journal of Drug and Alcohol Abuse, The Journal of Nervous and Mental Disease, Journal of Substance Abuse Treatment, JAMA and Journal of Drug Issues.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.